164 related articles for article (PubMed ID: 38530439)
21. [Croatian guidelines for use of eicosapentaenoic acid and megestrol acetate in cancer cachexia syndrome].
Krznarić Z; Juretić A; Samija M; Dintinjana RD; Vrdoljak E; Samarzija M; Kolacek S; Vrbanec D; Prgomet D; Ivkić M; Zelić M;
Lijec Vjesn; 2007 Dec; 129(12):381-6. PubMed ID: 18383739
[TBL] [Abstract][Full Text] [Related]
22. Venous thromboembolism (VTE) in patients with advanced gastric cancer: an Asian experience.
Kang MJ; Ryoo BY; Ryu MH; Koo DH; Chang HM; Lee JL; Kim TW; Kang YK
Eur J Cancer; 2012 Mar; 48(4):492-500. PubMed ID: 22169121
[TBL] [Abstract][Full Text] [Related]
23. A retrospective study of the association between megestrol acetate administration and mortality among nursing home residents with clinically significant weight loss.
Bodenner D; Spencer T; Riggs AT; Redman C; Strunk B; Hughes T
Am J Geriatr Pharmacother; 2007 Jun; 5(2):137-46. PubMed ID: 17719516
[TBL] [Abstract][Full Text] [Related]
24. Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled study.
Yeh SS; Wu SY; Lee TP; Olson JS; Stevens MR; Dixon T; Porcelli RJ; Schuster MW
J Am Geriatr Soc; 2000 May; 48(5):485-92. PubMed ID: 10811540
[TBL] [Abstract][Full Text] [Related]
25. Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial.
De Conno F; Martini C; Zecca E; Balzarini A; Venturino P; Groff L; Caraceni A
Eur J Cancer; 1998 Oct; 34(11):1705-9. PubMed ID: 9893656
[TBL] [Abstract][Full Text] [Related]
26. Cytokine involvement in cancer anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate on cytokine downregulation and improvement of clinical symptoms.
Mantovani G; Macciò A; Lai P; Massa E; Ghiani M; Santona MC
Crit Rev Oncog; 1998; 9(2):99-106. PubMed ID: 9973244
[TBL] [Abstract][Full Text] [Related]
27. A randomized, double-blind, placebo-controlled clinical trial of megestrol acetate as an appetite stimulant in children with weight loss due to cancer and/or cancer therapy.
Cuvelier GD; Baker TJ; Peddie EF; Casey LM; Lambert PJ; Distefano DS; Wardle MG; Mychajlunow BA; Romanick MA; Dix DB; Wilson BA
Pediatr Blood Cancer; 2014 Apr; 61(4):672-9. PubMed ID: 24167059
[TBL] [Abstract][Full Text] [Related]
28. Megestrol acetate in cachexia and anorexia.
Yeh SS; Schuster MW
Int J Nanomedicine; 2006; 1(4):411-6. PubMed ID: 17722275
[TBL] [Abstract][Full Text] [Related]
29. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia.
Loprinzi CL; Ellison NM; Schaid DJ; Krook JE; Athmann LM; Dose AM; Mailliard JA; Johnson PS; Ebbert LP; Geeraerts LH
J Natl Cancer Inst; 1990 Jul; 82(13):1127-32. PubMed ID: 2193166
[TBL] [Abstract][Full Text] [Related]
30. Treating malnutrition with megestrol acetate: literature review and review of our experience.
Karcic E; Philpot C; Morley JE
J Nutr Health Aging; 2002 May; 6(3):191-200. PubMed ID: 12152625
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of megestrol acetate in cancer cachexia and anorexia. A placebo-controlled study.
Feliu J; González-Barón M; Berrocal A; Artal A; Ordóñez A; Garrido P; Zamora P; García de Paredes ML; Montero JM
Am J Clin Oncol; 1992 Oct; 15(5):436-40. PubMed ID: 1524045
[TBL] [Abstract][Full Text] [Related]
32. Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.
Loprinzi CL; Michalak JC; Schaid DJ; Mailliard JA; Athmann LM; Goldberg RM; Tschetter LK; Hatfield AK; Morton RF
J Clin Oncol; 1993 Apr; 11(4):762-7. PubMed ID: 8478668
[TBL] [Abstract][Full Text] [Related]
33. Clinical studies on the treatment of cancer cachexia with megestrol acetate plus thalidomide.
Wen HS; Li X; Cao YZ; Zhang CC; Yang F; Shi YM; Peng LM
Chemotherapy; 2012; 58(6):461-7. PubMed ID: 23406994
[TBL] [Abstract][Full Text] [Related]
34. Venous thromboembolism in oesophago-gastric carcinoma: incidence of symptomatic and asymptomatic events following chemotherapy and surgery.
Rollins KE; Peters CJ; Safranek PM; Ford H; Baglin TP; Hardwick RH
Eur J Surg Oncol; 2011 Dec; 37(12):1072-7. PubMed ID: 21925829
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of plasma prostate specific antigen after megestrol acetate treatment in patients with metastatic breast carcinoma.
Diamandis EP; Helle SI; Yu H; Melegos DN; Lundgren S; Lonning PE
Cancer; 1999 Feb; 85(4):891-8. PubMed ID: 10091767
[TBL] [Abstract][Full Text] [Related]
36. Cumulative incidence, risk factors and prognostic impact of venous thromboembolism in Japanese patients with advanced gastric cancer.
Arai H; Hironaka S; Minashi K; Denda T; Shimokawa M; Yamaguchi T
Jpn J Clin Oncol; 2017 Oct; 47(10):942-948. PubMed ID: 28981740
[TBL] [Abstract][Full Text] [Related]
37. Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival.
Ramos JD; Casey MF; Crabb SJ; Bamias A; Harshman LC; Wong YN; Bellmunt J; De Giorgi U; Ladoire S; Powles T; Pal SK; Niegisch G; Recine F; Alva A; Agarwal N; Necchi A; Vaishampayan UN; Rosenberg JE; Galsky MD; Yu EY;
Cancer Med; 2017 Jan; 6(1):186-194. PubMed ID: 28000388
[TBL] [Abstract][Full Text] [Related]
38. The effect of cyproheptadine hydrochloride (periactin) and megestrol acetate (megace) on weight in children with cancer/treatment-related cachexia.
Couluris M; Mayer JL; Freyer DR; Sandler E; Xu P; Krischer JP
J Pediatr Hematol Oncol; 2008 Nov; 30(11):791-7. PubMed ID: 18989154
[TBL] [Abstract][Full Text] [Related]
39. The effects of megestrol acetate on nutrition, inflammation and quality of life in elderly haemodialysis patients.
Zheng Z; Chen J; He D; Xu Y; Chen L; Zhang T
Int Urol Nephrol; 2019 Sep; 51(9):1631-1638. PubMed ID: 31359357
[TBL] [Abstract][Full Text] [Related]
40. Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: a randomised placebo-controlled trial. Australasian Megestrol Acetate Cooperative Study Group.
Beller E; Tattersall M; Lumley T; Levi J; Dalley D; Olver I; Page J; Abdi E; Wynne C; Friedlander M; Boadle D; Wheeler H; Margrie S; Simes RJ
Ann Oncol; 1997 Mar; 8(3):277-83. PubMed ID: 9137798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
